References
- Sharp G C, Irwin W S, Tan E M, Gould R G, Holman H R. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 148–59
- Clotet B, Guardia J, Pigray C, et al. Incidence and clinical significance of anti-ENA antibodies in systemic lupus erythematosus. Estimation by counter-immunoelectro-phoresis. Scand J Rheumatol 1984; 13: 15–20
- deKlerk L S, Meijers K AE, Cats A. Is MCTD a distinct disease entity? Comparison of clinical and laboratory findings in MCTD, SLE, PSS, and RA patients. Clin Rheumatol 1989; 1: 29–36
- Ruuska P, Hämeenkorpi R, Forsberg S, et al. HLA antigen differences between mixed connective tissue disease (MCTD) and systemic lupus erythematosus (SLE). Ann Rheum Dis 1992; 51: 52–5
- Alarcon-Segovia D: Mixed connective tissue disease. Some statements. Clin Rheumatol 1982; 1: 81–9
- Tan E M, Cohen A S, Fries J F, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
- Tan E M. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581–90
- Fox R I, Robinson C A, Curd J G, Kozin F, Howell F V. Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum 1986; 29: 577–85
- Nakamura R M, Peebles C L, Tan E M. Microhemagglutination test for detection of antibodies to nuclear Sm and ribonucleoprotein antigens in systemic lupus erythematosus and related diseases. Am J Clin Pathol 1978; 70: 800–7
- Dorsch C A, White G M, Berzofsky R N. The measurement of antibodies to extractable nuclear antigen. Am J Clin Pathol 1979; 71: 333–7
- Ilonen J, Lagerstedt A, Koskimies S, Reunanen M. HLA-Dw1 and BfF as protective markers in multiple sclerosis. J Neuroimmunol 1983; 5: 283–8
- Sharp G C. Diagnostic criteria for classification of MCTD. Mixed connective tissue disease and anti-nuclear antibodies, R Kasukawa, G C Sharp. Elsevier, Amsterdam 1987; 23–32
- Kasukawa R, Tojo T, Miyawaki S, . Preliminary diagnostic criteria for classification of mixed connective tissue disease. Mixed connective tissue disease and anti-nuclear antibodies, R Kasukawa, G C Sharp, et al. Elsevier, Amsterdam 1987; 41–7
- Arnett F C, Edworthy S M, Bloch D A, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
- Black C M, Maddison P J, Welsh K I, Bernstein R, Wood-row J C, Pereira R S. HLA and immunoglobulin allotypes in mixed connective tissue disease. Arthritis Rheum 1988; 31: 131–4
- Smolen J S, Klippel J H, Penner E, et al. HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. Ann Rheum Dis 1987; 46: 457–42
- Genth E, Zarnowski H, Mierau R, Woltmann D, Hartl P W. HLA-DR4 and Gm(1, 3: 5.21) are associated with U1–nRNP antibody positive connective tissue disease. Ann Rheum Dis 1987; 46: 189–96
- Reichlin M, Harley J B. Immune response to the RNA protein particles in systemic lupus erythematosus. A distinctive dichotomy. Am J Med 1988; 85(6A)35–7
- Hoffman R W, Rettenmaier L J, Takeda Y, et al. Human autoantibodies against the 70–kd polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients. Arthritis Rheum 1990; 33: 666–73
- Habets W J, Hoet M H, van Venrooij W J. Epitope patterns of anti-RNP antibodies in rheumatic diseases. Evidence for an antigen-driven autoimmune response. Arthritis Rheum 1990; 33: 834–41
- Ganczarczyk L, Urowitz M B, Gladman D D. “Latent lupus”. J Rheumatol 1989; 16: 475–8
- Piirainen H I, Kurki P T. Clinical and serological follow-up of patients with polyarthritis. Raynaud's phenomenon, and circulating RNP antibodies. Scand J Rheumatol 1990; 19: 51–6
- Gregersen P K, Silver J, Winchester R J. The shared epitope hypothesis. Arthritis Rheum 1987; 30: 1205–13
- Eisenberg R, Dyer K, Craven S Y, et al. Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm. J Clin Invest 1985; 75: 1270–7